FiercePharma· @FiercePharma · X·· 4 小时前精选AI 评分62
AI 导读
日本药企盐野义（Shionogi）宣布与IntraBio达成20亿美元交易，接手其核心资产Aqneursa。数周前，IntraBio刚为Aqneursa取得标签扩展。原文链接：https://www.fiercepharma.com/pharma/shionogi-strikes-2b-deal-intrabio-heels-fda-approval
推荐理由
交易发生在Aqneursa获FDA标签扩展数周后，读者可据此观察罕见病资产在监管进展后的估值节奏。
正文
Just weeks after IntraBio secured a label expansion for its lead asset Aqneursa, Japanese drugmaker Shionogi is moving in to take the reins. https://www.fiercepharma.com/pharma/shionogi-strikes-2b-deal-intrabio-heels-fda-approval
来源：FiercePharma · x.com